应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
BL Blackline Inc.
盘前交易 07-11 05:44:42 EDT
56.01
-0.62
-1.09%
盘前
55.31
-0.70
-1.25%
05:31 EDT
最高
57.17
最低
55.96
成交量
53.86万
今开
56.58
昨收
56.63
日振幅
2.14%
总市值
34.91亿
流通市值
28.97亿
总股本
6,232万
成交额
3,043万
换手率
1.04%
流通股本
5,173万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
BlackLine获坎托菲茨杰拉德公司首次覆盖，给予中性评级, 目标价58.00美元。
金融界 · 06-03
BlackLine获坎托菲茨杰拉德公司首次覆盖，给予中性评级, 目标价58.00美元。
医药生物行业观察：信达生物IBI363、科伦博泰SKB264、百利天恒BL-B01D1领衔国产创新药突破
金融界 · 06-01
医药生物行业观察：信达生物IBI363、科伦博泰SKB264、百利天恒BL-B01D1领衔国产创新药突破
百利天恒(688506.SH)：注射用BL-M07D1(HER2ADC)用于HER2低表达复发或转移性乳腺癌III期临床试验完成首例受试者入组
智通财经 · 05-30
百利天恒(688506.SH)：注射用BL-M07D1(HER2ADC)用于HER2低表达复发或转移性乳腺癌III期临床试验完成首例受试者入组
Blackline, Inc.2025财年第一财季实现净利润6.06百万美元，同比减少44.04%
市场透视 · 05-11
Blackline, Inc.2025财年第一财季实现净利润6.06百万美元，同比减少44.04%
异动解读 | Blackline盘中大涨7.18%，多家券商上调目标价
异动解读 · 05-07
异动解读 | Blackline盘中大涨7.18%，多家券商上调目标价
Blackline, Inc.盘中异动 早盘急速上涨6.43%报49.65美元
市场透视 · 05-07
Blackline, Inc.盘中异动 早盘急速上涨6.43%报49.65美元
异动解读 | Blackline股价盘前大涨6.75%，Piper Sandler上调目标价
异动解读 · 05-07
异动解读 | Blackline股价盘前大涨6.75%，Piper Sandler上调目标价
异动解读 | Blackline股价盘前飙升6.75%，受多家券商上调目标价推动
异动解读 · 05-07
异动解读 | Blackline股价盘前飙升6.75%，受多家券商上调目标价推动
高盛：维持BlackLine(BL.US)评级，由卖出调整至卖出评级, 目标价由51.00美元调整至43.00美元。
金融界 · 04-17
高盛：维持BlackLine(BL.US)评级，由卖出调整至卖出评级, 目标价由51.00美元调整至43.00美元。
百利天恒(688506.SH)：注射用BL-B01D1联合用药治疗多种晚期实体瘤获批II期临床试验
智通财经 · 04-15
百利天恒(688506.SH)：注射用BL-B01D1联合用药治疗多种晚期实体瘤获批II期临床试验
DA Davidson：维持BlackLine(BL.US)评级，由买入调整至买入评级, 目标价由58.00美元调整至55.00美元。
金融界 · 04-14
DA Davidson：维持BlackLine(BL.US)评级，由买入调整至买入评级, 目标价由58.00美元调整至55.00美元。
【百利天恒：BL-B01D1（EGFR×HER3 双抗 ADC）联合奥希替尼用于一线 EGFR 突变型局部晚期或转移性非小细胞肺癌 III 期临床试验完成首例受试者入组】金融界3月2日消息，百利天恒自主研发的创新生物药注射用 BL-B01D1（EGFR×HER3 双抗 ADC）联合奥希替尼用于一线 EGFR 突变型局部晚期或转移性非小细胞肺癌的 III 期临床试验已于近日完成首例受试者入组。BL-B01D1 是全球独家处于 III 期注册临床试验阶段的可同时靶向 EGFR 和 HER3 的双抗 ADC 药物。截至目前，BL-B01D1 正在中国和美国进行约 30 项针对多种肿瘤类型的临床试验，除本次新入组的临床试验外，其在肺癌、乳腺癌、鼻咽癌、食管鳞癌等 7 项国内 III 期注册临床试验也处于受试者入组阶段。药品需完成临床试验并通过审评审批方可上市销售，且医药产品具有高科技、高风险等特点，容易受到不确定性因素影响。
金融界 · 03-02
【百利天恒：BL-B01D1（EGFR×HER3 双抗 ADC）联合奥希替尼用于一线 EGFR 突变型局部晚期或转移性非小细胞肺癌 III 期临床试验完成首例受试者入组】金融界3月2日消息，百利天恒自主研发的创新生物药注射用 BL-B01D1（EGFR×HER3 双抗 ADC）联合奥希替尼用于一线 EGFR 突变型局部晚期或转移性非小细胞肺癌的 III 期临床试验已于近日完成首例受试者入组。BL-B01D1 是全球独家处于 III 期注册临床试验阶段的可同时靶向 EGFR 和 HER3 的双抗 ADC 药物。截至目前，BL-B01D1 正在中国和美国进行约 30 项针对多种肿瘤类型的临床试验，除本次新入组的临床试验外，其在肺癌、乳腺癌、鼻咽癌、食管鳞癌等 7 项国内 III 期注册临床试验也处于受试者入组阶段。药品需完成临床试验并通过审评审批方可上市销售，且医药产品具有高科技、高风险等特点，容易受到不确定性因素影响。
百利天恒(688506.SH)注射用BL-M07D1(HER2-ADC)获II/III期临床试验批准通知书
智通财经 · 02-18
百利天恒(688506.SH)注射用BL-M07D1(HER2-ADC)获II/III期临床试验批准通知书
Blackline, Inc.2024财年实现净利润1.61亿美元，同比增加204.75%
市场透视 · 02-15
Blackline, Inc.2024财年实现净利润1.61亿美元，同比增加204.75%
Blackline, Inc.股价重挫14.28% 市值跌4.85亿美元
市场透视 · 02-12
Blackline, Inc.股价重挫14.28% 市值跌4.85亿美元
BlackLine第四季度调整后的每股收益为$0.47，低于预期的$0.50，销售额为$1.6946亿，高于预期的$1.6834亿
财报速递 · 02-11
BlackLine第四季度调整后的每股收益为$0.47，低于预期的$0.50，销售额为$1.6946亿，高于预期的$1.6834亿
百利天恒(688506.SH)：注射用BL-M07D1(HER2-ADC)III期临床试验获批准
智通财经 · 02-07
百利天恒(688506.SH)：注射用BL-M07D1(HER2-ADC)III期临床试验获批准
Blackline, Inc.盘中异动 早盘股价大涨5.34%
市场透视 · 01-30
Blackline, Inc.盘中异动 早盘股价大涨5.34%
B of A Securities：上调BlackLine(BL.US)评级，由低于大市调整至买入评级, 目标价由50.00美元调整至75.00美元。
金融界 · 01-30
B of A Securities：上调BlackLine(BL.US)评级，由低于大市调整至买入评级, 目标价由50.00美元调整至75.00美元。
Blackline, Inc.盘中异动 下午盘股价大涨5.01%报64.81美元
市场透视 · 01-28
Blackline, Inc.盘中异动 下午盘股价大涨5.01%报64.81美元
加载更多
公司概况
公司名称：
Blackline Inc.
所属市场：
NASDAQ
上市日期：
--
主营业务：
BlackLine, Inc.以BlackLine Systems, Inc之名成立于2001年。该公司已经创建了一个全面的基于云计算的软件平台，旨在为所有类型和规模的组织变革和现代化的会计和财务运作。他们的安全可扩展的平台支持关键会计流程，如财务结算，对账，公司间的会计和控制的保证等。通过引入软件来自动化这些流程并使其能够持续运行，他们授权客户提高其财务报告的完整性，提高效率并增强其运营的实时可见性。
发行价格：
--
{"stockData":{"symbol":"BL","market":"US","secType":"STK","nameCN":"Blackline Inc.","latestPrice":56.01,"timestamp":1752177600000,"preClose":56.63,"halted":0,"volume":538584,"hourTrading":{"tag":"盘前","latestPrice":55.31,"preClose":56.01,"latestTime":"05:31 EDT","volume":6,"amount":332.31999,"timestamp":1752226282640},"delay":0,"floatShares":51731718,"shares":62320133,"eps":1.409829,"marketStatus":"盘前交易","change":-0.62,"latestTime":"07-11 05:44:42 EDT","open":56.58,"high":57.17,"low":55.96,"amount":30429182.73816,"amplitude":0.021367,"askPrice":57.35,"askSize":20,"bidPrice":55.06,"bidSize":36,"shortable":3,"etf":0,"ttmEps":1.409829,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752240600000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1477627200000,"exchange":"NASDAQ","adjPreClose":56.01,"preHourTrading":{"tag":"盘前","latestPrice":55.31,"preClose":56.01,"latestTime":"05:31 EDT","volume":6,"amount":332.31999,"timestamp":1752226282640},"postHourTrading":{"tag":"盘后","latestPrice":56.01,"preClose":56.01,"latestTime":"16:10 EDT","volume":9777,"amount":547609.73,"timestamp":1752178203831},"volumeRatio":0.9677252428664525,"impliedVol":0.2832,"impliedVolPercentile":0.0522},"requestUrl":"/m/hq/s/BL","defaultTab":"news","newsList":[{"id":"2540722817","title":"BlackLine获坎托菲茨杰拉德公司首次覆盖，给予中性评级, 目标价58.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2540722817","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540722817?lang=zh_cn&edition=full","pubTime":"2025-06-03 21:31","pubTimestamp":1748957480,"startTime":"0","endTime":"0","summary":"BlackLine(BL.US)获坎托菲茨杰拉德公司首次覆盖，给予中性评级, 目标价58.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603213601976ff6d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603213601976ff6d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BL"],"gpt_icon":0},{"id":"2540735982","title":"医药生物行业观察：信达生物IBI363、科伦博泰SKB264、百利天恒BL-B01D1领衔国产创新药突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2540735982","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540735982?lang=zh_cn&edition=full","pubTime":"2025-06-01 13:28","pubTimestamp":1748755724,"startTime":"0","endTime":"0","summary":"国产创新药企业在此次会议上表现亮眼，信达生物、科伦博泰、百利天恒等多家企业展示了包括双抗、ADC在内的创新分子数据，进一步印证了中国创新药在全球范围内的研发实力与临床价值。此外，百利天恒的EGFRxHER3双抗ADCBL-B01D1在小细胞肺癌及携带非经典EGFR突变的NSCLC患者中，公布了Ib期临床的积极数据。例如，百利天恒的BL-B01D1在2023年ASCO公布数据后，迅速与BMS达成84亿美元合作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/01132850802291.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU1969619763.USD","159992","01801","BK0239","LU1815336091.USD","06978","LU2488822045.USD","BL","BK1161","BK4023","688506","BK1583","BK1589","LU2328871848.SGD","163118","LU0757428866.USD","000808.SH","BK1574"],"gpt_icon":0},{"id":"2539227448","title":"百利天恒(688506.SH)：注射用BL-M07D1(HER2ADC)用于HER2低表达复发或转移性乳腺癌III期临床试验完成首例受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2539227448","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539227448?lang=zh_cn&edition=full","pubTime":"2025-05-30 21:02","pubTimestamp":1748610146,"startTime":"0","endTime":"0","summary":"近日，BL-M07D1单药治疗HER2低表达复发或转移性乳腺癌的临床研究已进入III期临床试验阶段并完成首例受试者入组。截至目前，BL-M07D1正在国内外开展12项临床试验，包括3个III期、3个II期、3个I/II期及3个I期临床试验，覆盖二线及以上HER2阳性乳腺癌、HER2阳性乳腺癌术后辅助、HER2阳性乳腺癌新辅助治疗和HER2低表达乳腺癌，以及肺癌、消化道肿瘤、泌尿系统肿瘤和妇科肿瘤等多项适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1299911.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4134","LU1815336091.USD","BK0239","LU0757428866.USD","BK1583","03347","BK1141","688506","III","BK4023","BK1576","BL"],"gpt_icon":0},{"id":"2534226238","title":"Blackline, Inc.2025财年第一财季实现净利润6.06百万美元，同比减少44.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534226238","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534226238?lang=zh_cn&edition=full","pubTime":"2025-05-12 00:01","pubTimestamp":1746979292,"startTime":"0","endTime":"0","summary":"5月12日，Blackline, Inc.公布财报，公告显示公司2025财年第一财季净利润为6.06百万美元，同比减少44.04%；其中营业收入为1.67亿美元，同比增加6.37%，每股基本收益为0.10美元。从资产负债表来看，Blackline, Inc.总负债13.27亿美元，其中短期债务2.33亿美元，资产负债比为1.35，流动比率为1.66。机构评级：截至2025年5月12日，当前有11家机构对Blackline, Inc.目标价做出预测，其中目标均价为56.91美元，其中最低目标价为45.00美元，最高目标价为80.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512000453a6db2d21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512000453a6db2d21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BL"],"gpt_icon":0},{"id":"1190369477","title":"异动解读 | Blackline盘中大涨7.18%，多家券商上调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1190369477","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190369477?lang=zh_cn&edition=full","pubTime":"2025-05-07 21:50","pubTimestamp":1746625847,"startTime":"0","endTime":"0","summary":"财务自动化软件公司Blackline周三盘中股价大幅上涨7.18%，引发市场广泛关注。消息面上，多家华尔街券商上调了对Blackline的目标价。其中，Piper Sandler将该公司目标价从46美元上调至50美元，涨幅约8.7%；BMO也将Blackline的目标价从50美元上调至53美元，上调幅度达6%。分析师的积极评价反映出对Blackline未来业务发展前景的信心增强。作为一家提供云端财务软件解决方案的公司，Blackline在数字化转型浪潮中持续受益。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BL"],"gpt_icon":0},{"id":"2533939111","title":"Blackline, Inc.盘中异动 早盘急速上涨6.43%报49.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533939111","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533939111?lang=zh_cn&edition=full","pubTime":"2025-05-07 21:34","pubTimestamp":1746624846,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日21时34分，Blackline, Inc.股票出现波动，股价大幅上涨6.43%。截至发稿，该股报49.65美元/股，成交量6.1107万股，换手率0.10%，振幅3.11%。Blackline, Inc.股票所在的软件服务行业中，整体涨幅为0.08%。Blackline, Inc.公司简介：BlackLine Inc 致力于提供以软件即服务 形式交付的财务会计结算解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507213406a6d66b6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507213406a6d66b6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BL","LU0757428866.USD","BK4023","LU1815336091.USD"],"gpt_icon":0},{"id":"1155168076","title":"异动解读 | Blackline股价盘前大涨6.75%，Piper Sandler上调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1155168076","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155168076?lang=zh_cn&edition=full","pubTime":"2025-05-07 21:29","pubTimestamp":1746624564,"startTime":"0","endTime":"0","summary":"周三盘前，财务自动化软件公司Blackline Inc.股价大幅上涨6.75%，引发投资者关注。消息面上，知名投资银行Piper Sandler对Blackline股票给出了更为乐观的评估。Piper Sandler分析师将Blackline的目标价从46美元上调至50美元，这一调整反映了分析师对公司未来表现的信心增强。目标价的上调通常被视为对公司基本面和未来增长前景的积极看法。Piper Sandler的这一举动可能刺激了投资者对Blackline的兴趣，从而推动了股价在盘前交易中的显著上涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BL"],"gpt_icon":0},{"id":"1104995989","title":"异动解读 | Blackline股价盘前飙升6.75%，受多家券商上调目标价推动","url":"https://stock-news.laohu8.com/highlight/detail?id=1104995989","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104995989?lang=zh_cn&edition=full","pubTime":"2025-05-07 21:28","pubTimestamp":1746624522,"startTime":"0","endTime":"0","summary":"财务软件公司Blackline Inc.周三盘前股价大涨6.75%，引发投资者关注。这波涨势主要受到多家华尔街券商上调Blackline目标价的推动。同时，BMO也将Blackline的目标价从50美元上调至53美元，涨幅达6%。分析师的积极看法反映出对Blackline未来业务发展的信心增强。Blackline作为一家提供云端财务软件解决方案的公司，近年来在数字化转型浪潮中受益。券商上调目标价可能暗示公司在市场份额、收入增长或盈利能力等方面有所突破。投资者对此反应积极，推动股价在盘前交易中显著上涨。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | Blackline股价盘前飙升6.75%，受多家券商上调目标价推动","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BL"],"gpt_icon":0},{"id":"2528144721","title":"高盛：维持BlackLine(BL.US)评级，由卖出调整至卖出评级, 目标价由51.00美元调整至43.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2528144721","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528144721?lang=zh_cn&edition=full","pubTime":"2025-04-18 01:41","pubTimestamp":1744911695,"startTime":"0","endTime":"0","summary":"高盛：维持BlackLine(BL.US)评级，由卖出调整至卖出评级, 目标价由51.00美元调整至43.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/18014149640004.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BL"],"gpt_icon":0},{"id":"2527467851","title":"百利天恒(688506.SH)：注射用BL-B01D1联合用药治疗多种晚期实体瘤获批II期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2527467851","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527467851?lang=zh_cn&edition=full","pubTime":"2025-04-15 17:42","pubTimestamp":1744710140,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百利天恒(688506.SH)发布公告，公司近日收到国家药品监督管理局(NMPA)正式批准签发的4个《药物临床试验批准通知书》，公司自主研发的创新生物药注射用BL-B01D1(EGFR×HER3双抗ADC)的4个联合用药的II期临床试验获得批准。根据《中华人民共和国药品管理法》及有关规定，经审查，注射用BL-B01D1临床试验符合药品注册的有关要求，同意本品开展联合仑伐替尼用于晚期肝癌、联合阿昔替尼±帕博利珠单抗用于晚期肾癌、联合贝伐珠单抗±化疗用于晚期结直肠癌、联合帕博利珠单抗±化疗用于晚期胆道恶性肿瘤的临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1278914.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BL","BK4023","688506","03347","BK1583","BK1576","LU1815336091.USD","BK0239","LU0757428866.USD","BK1141"],"gpt_icon":0},{"id":"2527755110","title":"DA Davidson：维持BlackLine(BL.US)评级，由买入调整至买入评级, 目标价由58.00美元调整至55.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2527755110","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527755110?lang=zh_cn&edition=full","pubTime":"2025-04-15 03:03","pubTimestamp":1744657382,"startTime":"0","endTime":"0","summary":"DA Davidson：维持BlackLine(BL.US)评级，由买入调整至买入评级, 目标价由58.00美元调整至55.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/15030349536772.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BL"],"gpt_icon":0},{"id":"2516364590","title":"【百利天恒：BL-B01D1（EGFR×HER3 双抗 ADC）联合奥希替尼用于一线 EGFR 突变型局部晚期或转移性非小细胞肺癌 III 期临床试验完成首例受试者入组】金融界3月2日消息，百利天恒自主研发的创新生物药注射用 BL-B01D1（EGFR×HER3 双抗 ADC）联合奥希替尼用于一线 EGFR 突变型局部晚期或转移性非小细胞肺癌的 III 期临床试验已于近日完成首例受试者入组。BL-B01D1 是全球独家处于 III 期注册临床试验阶段的可同时靶向 EGFR 和 HER3 的双抗 ADC 药物。截至目前，BL-B01D1 正在中国和美国进行约 30 项针对多种肿瘤类型的临床试验，除本次新入组的临床试验外，其在肺癌、乳腺癌、鼻咽癌、食管鳞癌等 7 项国内 III 期注册临床试验也处于受试者入组阶段。药品需完成临床试验并通过审评审批方可上市销售，且医药产品具有高科技、高风险等特点，容易受到不确定性因素影响。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516364590","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516364590?lang=zh_cn&edition=full","pubTime":"2025-03-02 15:34","pubTimestamp":1740900843,"startTime":"0","endTime":"0","summary":"金融界3月2日消息，百利天恒自主研发的创新生物药注射用 BL-B01D1 联合奥希替尼用于一线 EGFR 突变型局部晚期或转移性非小细胞肺癌的 III 期临床试验已于近日完成首例受试者入组。BL-B01D1 是全球独家处于 III 期注册临床试验阶段的可同时靶向 EGFR 和 HER3 的双抗 ADC 药物。截至目前，BL-B01D1 正在中国和美国进行约 30 项针对多种肿瘤类型的临床试验，除本次新入组的临床试验外，其在肺癌、乳腺癌、鼻咽癌、食管鳞癌等 7 项国内 III 期注册临床试验也处于受试者入组阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/02153448475153.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4080","159839","BK4023","ADC","09939","BK1515","BK1583","LU1815336091.USD","BK1161","03347","BL","BK4231","BK4134","BK1576","III","688506","BK1141","BK1574","159938","BK0239","LU0757428866.USD"],"gpt_icon":0},{"id":"2512163139","title":"百利天恒(688506.SH)注射用BL-M07D1(HER2-ADC)获II/III期临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2512163139","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512163139?lang=zh_cn&edition=full","pubTime":"2025-02-18 17:04","pubTimestamp":1739869479,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百利天恒 公告，公司于近日收到国家药品监督管理局正式批准签发的《药物临床试验批准通知书》,公司自主研发的创新生物药注射用BL-M07D1的II/III期临床试验获得批准。据悉，BL-M07D1是一种靶向HER2的创新ADC，具有best-in-class潜力，已在临床试验中展示出显著的抗肿瘤功效。截至本公告披露日，除本次新获得批准的临床试验外，BL-M07D1正于中国及美国的10项I/II/III期临床试验中作为单药或联用进行评估。各项临床研究包括各种HER2表达/突变的实体瘤的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1251148.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ADC","BK4134","LU1815336091.USD","BK0239","BK4080","BK1583","LU0757428866.USD","03347","BK1141","688506","III","BK4023","BK1576","BL","BK4231"],"gpt_icon":0},{"id":"2511670288","title":"Blackline, Inc.2024财年实现净利润1.61亿美元，同比增加204.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511670288","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511670288?lang=zh_cn&edition=full","pubTime":"2025-02-16 00:00","pubTimestamp":1739635247,"startTime":"0","endTime":"0","summary":"2月16日，Blackline, Inc.公布财报，公告显示公司2024财年净利润为1.61亿美元，同比增加204.75%；其中营业收入为6.53亿美元，同比增加10.68%，每股基本收益为2.59美元。从资产负债表来看，Blackline, Inc.总负债13.42亿美元，其中短期债务3.59百万美元，资产负债比为1.36，流动比率为2.59。机构评级：截至2025年2月16日，当前有10家机构对Blackline, Inc.目标价做出预测，其中目标均价为64.80美元，其中最低目标价为51.00美元，最高目标价为80.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250216000102a24729b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250216000102a24729b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BL"],"gpt_icon":0},{"id":"2510034123","title":"Blackline, Inc.股价重挫14.28% 市值跌4.85亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510034123","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510034123?lang=zh_cn&edition=full","pubTime":"2025-02-12 22:32","pubTimestamp":1739370722,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日22时32分，Blackline, Inc.股票出现波动，股价快速下挫14.28%。截至发稿，该股报54.35美元/股，成交量11.2069万股，换手率0.18%，振幅1.37%。Blackline, Inc.股票所在的软件服务行业中，整体跌幅为1.21%。Blackline, Inc.公司简介：BlackLine Inc 致力于提供以软件即服务 形式交付的财务会计结算解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212223202abcc5d49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212223202abcc5d49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BL","LU1815336091.USD","LU0757428866.USD","BK4023"],"gpt_icon":0},{"id":"1135492876","title":"BlackLine第四季度调整后的每股收益为$0.47，低于预期的$0.50，销售额为$1.6946亿，高于预期的$1.6834亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1135492876","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135492876?lang=zh_cn&edition=full","pubTime":"2025-02-12 05:12","pubTimestamp":1739308378,"startTime":"0","endTime":"0","summary":"BlackLine 报告的季度每股收益为$0.47，比分析师预期的$0.50低了6%。这比去年同期每股收益$0.69下降了31.88%。公司报告的季度销售额为$1.6946亿，超过了分析师预期的$1.6834亿，高出了0.66%。这比去年同期的$1.5573亿增长了8.82%。以上内容来自Benzinga Earnings专栏，原文如下：BlackLine reported quarterly earnings of $0.47 per share which missed the analyst consensus estimate of $0.50 by 6 percent. This is a 31.88 percent decrease over earnings of $0.69 per share from the same period last year. The company reported quarterly sales of $169.46 million which beat the analyst consensus estimate of $168","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"BlackLine第四季度调整后的每股收益为$0.47，低于预期的$0.50，销售额为$1.6946亿，高于预期的$1.6834亿","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BL"],"gpt_icon":0},{"id":"2509799007","title":"百利天恒(688506.SH)：注射用BL-M07D1(HER2-ADC)III期临床试验获批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2509799007","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509799007?lang=zh_cn&edition=full","pubTime":"2025-02-07 16:34","pubTimestamp":1738917290,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百利天恒(688506.SH)发布公告，公司于近日收到国家药品监督管理局(NMPA)正式批准签发的《药物临床试验批准通知书》,公司自主研发的创新生物药注射用BL-M07D1(HER2-ADC)的III期临床试验获得批准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1247092.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4134","BK1141","LU0757428866.USD","BL","BK4231","03347","ADC","BK4080","BK1583","BK0239","III","LU1815336091.USD","688506","BK1576","BK4023"],"gpt_icon":0},{"id":"2507362189","title":"Blackline, Inc.盘中异动 早盘股价大涨5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507362189","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507362189?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:31","pubTimestamp":1738247476,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时31分，Blackline, Inc.股票出现异动，股价急速上涨5.34%。Blackline, Inc.股票所在的软件服务行业中，整体跌幅为2.25%。其相关个股中，Alpha Modus Holdings, Inc.、Alpha Modus Holdings Inc C/Wts 13/12/2029 、Banzai International Inc C/Wts 14/12/2028 涨幅较大，Banzai International, Inc.、Alpha Modus Holdings, Inc.、Signing Day Sports, Inc.较为活跃，换手率分别为226.84%、158.87%、55.31%，振幅较大的相关个股有Alpha Modus Holdings, Inc.、Alpha Modus Holdings Inc C/Wts 13/12/2029 、讯鸟软件，振幅分别为20.13%、16.36%、9.22%。Blackline, Inc.公司简介：BlackLine Inc 致力于提供以软件即服务 形式交付的财务会计结算解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223116abbd4bfd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223116abbd4bfd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1815336091.USD","BL","BK4023","LU0757428866.USD"],"gpt_icon":0},{"id":"2507403496","title":"B of A Securities：上调BlackLine(BL.US)评级，由低于大市调整至买入评级, 目标价由50.00美元调整至75.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2507403496","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507403496?lang=zh_cn&edition=full","pubTime":"2025-01-30 20:42","pubTimestamp":1738240955,"startTime":"0","endTime":"0","summary":"B of A Securities：上调BlackLine(BL.US)评级，由低于大市调整至买入评级, 目标价由50.00美元调整至75.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/30204247909594.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BL"],"gpt_icon":0},{"id":"2507654435","title":"Blackline, Inc.盘中异动 下午盘股价大涨5.01%报64.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507654435","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507654435?lang=zh_cn&edition=full","pubTime":"2025-01-29 02:20","pubTimestamp":1738088457,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日02时20分，Blackline, Inc.股票出现波动，股价大幅上涨5.01%。截至发稿，该股报64.81美元/股，成交量39.189万股，换手率0.63%，振幅5.30%。Blackline, Inc.股票所在的软件服务行业中，整体涨幅为2.63%。Blackline, Inc.公司简介：BlackLine Inc 致力于提供以软件即服务 形式交付的财务会计结算解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501290220579875840e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501290220579875840e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BL","LU0757428866.USD","LU1815336091.USD","BK4023"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.blackline.com","stockEarnings":[{"period":"1week","weight":-0.0311},{"period":"1month","weight":0.0002},{"period":"3month","weight":0.2286},{"period":"6month","weight":0.0063},{"period":"1year","weight":0.1872},{"period":"ytd","weight":-0.0782}],"compareEarnings":[{"period":"1week","weight":0.0008},{"period":"1month","weight":0.0377},{"period":"3month","weight":0.1721},{"period":"6month","weight":0.0781},{"period":"1year","weight":0.1149},{"period":"ytd","weight":0.0678}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"BlackLine, Inc.以BlackLine Systems, Inc之名成立于2001年。该公司已经创建了一个全面的基于云计算的软件平台，旨在为所有类型和规模的组织变革和现代化的会计和财务运作。他们的安全可扩展的平台支持关键会计流程，如财务结算，对账，公司间的会计和控制的保证等。通过引入软件来自动化这些流程并使其能够持续运行，他们授权客户提高其财务报告的完整性，提高效率并增强其运营的实时可见性。","yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":0.029132},{"month":2,"riseRate":0.444444,"avgChangeRate":-0.005715},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.041166},{"month":4,"riseRate":0.555556,"avgChangeRate":0.011999},{"month":5,"riseRate":0.666667,"avgChangeRate":0.021207},{"month":6,"riseRate":0.888889,"avgChangeRate":0.033324},{"month":7,"riseRate":0.444444,"avgChangeRate":0.000033},{"month":8,"riseRate":0.625,"avgChangeRate":0.032708},{"month":9,"riseRate":0.625,"avgChangeRate":0.017548},{"month":10,"riseRate":0.5,"avgChangeRate":-0.021421},{"month":11,"riseRate":0.777778,"avgChangeRate":0.10276},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.009734}],"exchange":"NASDAQ","name":"Blackline Inc.","nameEN":"Blackline Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Blackline Inc.(BL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Blackline Inc.(BL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Blackline Inc.,BL,Blackline Inc.股票,Blackline Inc.股票老虎,Blackline Inc.股票老虎国际,Blackline Inc.行情,Blackline Inc.股票行情,Blackline Inc.股价,Blackline Inc.股市,Blackline Inc.股票价格,Blackline Inc.股票交易,Blackline Inc.股票购买,Blackline Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Blackline Inc.(BL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Blackline Inc.(BL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}